Annals of Oncology, 1569-8041

Journal

More filtering options
  1. 2013
  2. A randomized phase III trial on maintenance treatment with bevacizumab alone or in combination with erlotinib after chemotherapy and bevacizumab in metastatic colorectal cancer: the Nordic ACT Trial.

    Anders Johnsson, Helga Hagman, Frödin, J-E., Berglund, Å., Keldsen, N., Fernebro, E., Sundberg, J., De Pont Christensen, R., Garm Spindler, K-L., Bergström, D. & Jakobsen, A., 2013, In : Annals of Oncology. 24, 9, p. 2335-2341

    Research output: Contribution to journalArticle

  3. Consumption of fish and meats and risk of hepatocellular carcinoma: the European Prospective Investigation into Cancer and Nutrition (EPIC)

    Fedirko, V., Trichopolou, A., Bamia, C., Duarte-Salles, T., Trepo, E., Aleksandrova, K., Noethlings, U., Lukanova, A., Lagiou, P., Boffetta, P., Trichopoulos, D., Katzke, V. A., Overvad, K., Tjonneland, A., Hansen, L., Boutron-Ruault, M. C., Fagherazzi, G., Bastide, N., Panico, S., Grioni, S. & 24 others, Vineis, P., Palli, D., Tumino, R., Bueno-de-Mesquita, H. B., Peeters, P. H., Skeie, G., Engeset, D., Parr, C. L., Jakszyn, P., Sanchez, M. J., Barricarte, A., Amiano, P., Chirlaque, M., Quiros, J. R., Sund, M., Werner, M., Emily Sonestedt, Ulrika Ericson, Key, T. J., Khaw, K. T., Ferrari, P., Romieu, I., Riboli, E. & Jenab, M., 2013, In : Annals of Oncology. 24, 8, p. 2166-2173

    Research output: Contribution to journalArticle

  4. Diabetes mellitus, insulin treatment, diabetes duration, and risk of biliary tract cancer and hepatocellular carcinoma in a European cohort

    Schlesinger, S., Aleksandrova, K., Pischon, T., Jenab, M., Fedirko, V., Trepo, E., Overvad, K., Roswall, N., Tjonneland, A., Boutron-Ruault, M. C., Fagherazzi, G., Racine, A., Kaaks, R., Grote, V. A., Boeing, H., Trichopoulou, A., Pantzalis, M., Kritikou, M., Mattiello, A., Sieri, S. & 21 others, Sacerdote, C., Palli, D., Tumino, R., Peeters, P. H., Bueno-de-Mesquita, H. B., Weiderpass, E., Quiros, J. R., Zamora-Ros, R., Sanchez, M. J., Arriola, L., Ardanaz, E., Tormo, M. J., Peter Nilsson, Lindkvist, B., Sund, M., Rolandsson, O., Khaw, K. T., Wareham, N., Travis, R. C., Riboli, E. & Noethlings, U., 2013, In : Annals of Oncology. 24, 9, p. 2449-2455

    Research output: Contribution to journalArticle

  5. Dietary intake of acrylamide and pancreatic cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort

    Obon-Santacana, M., Slimani, N., Lujan-Barroso, L., Travier, N., Hallmans, G., Freisling, H., Ferrari, P., Boutron-Ruault, M. C., Racine, A., Clavel, F., Saieva, C., Pala, V., Tumino, R., Mattiello, A., Vineis, P., Argueelles, M., Ardanaz, E., Amiano, P., Navarro, C., Sanchez, M. J. & 24 others, Montes, E. M., Key, T., Khaw, K. -T., Wareham, N., Peeters, P. H., Trichopoulou, A., Bamia, C., Trichopoulos, D., Boeing, H., Kaaks, R., Katzke, V., Ye, W., Sund, M., Ulrika Ericson, Elisabet Wirfält, Overvad, K., Tjonneland, A., Olsen, A., Skeie, G., Asli, L. A., Weiderpass, E., Riboli, E., Bueno-De-Mesquita, H. B. & Duell, E. J., 2013, In : Annals of Oncology. 24, 10, p. 2645-2651

    Research output: Contribution to journalArticle

  6. Dose-densified chemoimmunotherapy followed by systemic central nervous system prophylaxis for younger high-risk diffuse large B-cell/follicular grade 3 lymphoma patients: results of a phase II Nordic Lymphoma Group study

    Holte, H., Leppa, S., Bjorkholm, M., Fluge, O., Jyrkkio, S., Delabie, J., Sundstrom, C., Karjalainen-Lindsberg, M. -L., Erlanson, M., Kolstad, A., Fossa, A., Ostenstad, B., Lofvenberg, E., Nordstrom, M., Janes, R., Pedersen, L. M., Anderson, H., Mats Jerkeman & Mikael Eriksson, 2013, In : Annals of Oncology. 24, 5, p. 1385-1392

    Research output: Contribution to journalArticle

  7. Impact of chemotherapy regimen and rituximab in adult Burkitt lymphoma: a retrospective population-based study from the Nordic Lymphoma Group.

    Wästerlid, T., Brown, P. N., Oskar Hagberg, Hagberg, H., Pedersen, L. M., D'Amore, F. & Mats Jerkeman, 2013, In : Annals of Oncology. 24, 7, p. 1879-1886

    Research output: Contribution to journalArticle

  8. Maintaining success, reducing treatment burden, focusing on survivorship: highlights from the third European consensus conference on diagnosis and treatment of germ-cell cancer

    Beyer, J., Albers, P., Altena, R., Aparicio, J., Bokemeyer, C., Busch, J., Cathomas, R., Cavallin-Ståhl, E., Clarke, N. W., Classen, J., Cohn-Cedermark, G., Dahl, A. A., Daugaard, G., De Giorgi, U., De Santis, M., De Wit, M., De Wit, R., Dieckmann, K. P., Fenner, M., Fizazi, K. & 39 others, Flechon, A., Fossa, S. D., Germa Lluch, J. R., Gietema, J. A., Gillessen, S., Aleksander Giwercman, Hartmann, J. T., Heidenreich, A., Hentrich, M., Honecker, F., Horwich, A., Huddart, R. A., Kliesch, S., Kollmannsberger, C., Krege, S., Laguna, M. P., Looijenga, L. H. J., Lorch, A., Lotz, J. P., Mayer, F., Necchi, A., Nicolai, N., Nuver, J., Oechsle, K., Oldenburg, J., Oosterhuis, J. W., Powles, T., Rajpert-De Meyts, E., Rick, O., Rosti, G., Salvioni, R., Schrader, M., Schweyer, S., Sedlmayer, F., Sohaib, A., Souchon, R., Tandstad, T., Winter, C. & Wittekind, C., 2013, In : Annals of Oncology. 24, 4, p. 878-888

    Research output: Contribution to journalReview article

  9. Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

    Senkus, E., Kyriakides, S., Penault-Llorca, F., Poortmans, P., Thompson, A., Sophia Zackrisson & Cardoso, F., 2013, In : Annals of Oncology. 24, p. 7-23

    Research output: Contribution to journalArticle

  10. The role of AIB1 and PAX2 in primary breast cancer: validation of AIB1 as a negative prognostic factor.

    Alkner, S., Bendahl, P., Grabau, D., Per Malmström, Mårten Fernö & Lisa Rydén, 2013, In : Annals of Oncology. 24, 5, p. 1244-1252

    Research output: Contribution to journalArticle

  11. 2012
  12. Acupuncture compared with placebo acupuncture in radiotherapy-induced nausea-a randomized controlled study

    Enblom, A., Anna Johnsson, Hammar, M., Onelov, E., Steineck, G. & Borjeson, S., 2012, In : Annals of Oncology. 23, 5, p. 1353-1361

    Research output: Contribution to journalArticle

  13. Adjuvant therapy in primary GIST: state-of-the-art

    Reichardt, P., Blay, J. -Y., Boukovinas, I., Brodowicz, T., Broto, J. M., Casali, P. G., Decatris, M., Mikael Eriksson, Gelderblom, H., Kosmidis, P., Le Cesne, A., Pousa, A. L., Schlemmer, M., Verweij, J. & Joensuu, H., 2012, In : Annals of Oncology. 23, 11, p. 2776-2781

    Research output: Contribution to journalReview article

  14. Autoimmune disease and subsequent digestive tract cancer by histology

    Kari Hemminki, Liu, X., Jianguang Ji, Jan Sundquist & Kristina Sundquist, 2012, In : Annals of Oncology. 23, 4, p. 927-U6

    Research output: Contribution to journalArticle

  15. Cancer of unknown primary (CUP): does cause of death and family history implicate hidden phenotypically changed primaries?

    Kari Hemminki, Bevier, M., Jan Sundquist & Hemminki, A., 2012, In : Annals of Oncology. 23, 10, p. 2720-2724

    Research output: Contribution to journalArticle

  16. CNS disease in younger patients with aggressive B-cell lymphoma: an analysis of patients treated on the Mabthera International Trial and trials of the German High-Grade Non-Hodgkin Lymphoma Study Group

    Schmitz, N., Zeynalova, S., Glass, B., Kaiser, U., Cavallin-Ståhl, E., Wolf, M., Haenel, M., Loeffler, M., Truemper, L. & Pfreundschuh, M., 2012, In : Annals of Oncology. 23, 5, p. 1267-1273

    Research output: Contribution to journalArticle

  17. Death causes in breast cancer patients

    Riihimaeki, M., Thomsen, H., Brandt, A., Jan Sundquist & Kari Hemminki, 2012, In : Annals of Oncology. 23, 3, p. 604

    Research output: Contribution to journalArticle

  18. First-line treatment of advanced ovarian cancer with paclitaxel/carboplatin with or without epirubicin (TEC versus TC)-a gynecologic cancer intergroup study of the NSGO, EORTC GCG and NCIC CTG

    Lindemann, K., Christensen, R. D., Vergote, I., Stuart, G., Izquierdo, M. A., Kaem, J., Havsteen, H., Eisenhauer, E., Ridderheim, M., Lopez, A. B., Hirte, H., Aavall-Lundquvist, E., Vrdoljak, E., Green, J. & Kristensen, G. B., 2012, In : Annals of Oncology. 23, 10, p. 2613-U31

    Research output: Contribution to journalArticle

  19. Helicobacter pylori infection assessed by ELISA and by immunoblot and noncardia gastric cancer risk in a prospective study: the Eurgast-EPIC project

    Gonzalez, C. A., Megraud, F., Buissonniere, A., Lujan Barroso, L., Agudo, A., Duell, E. J., Boutron-Ruault, M. C., Clavel-Chapelon, F., Palli, D., Krogh, V., Mattiello, A., Tumino, R., Sacerdote, C., Quiros, J. R., Sanchez-Cantalejo, E., Navarro, C., Barricarte, A., Dorronsoro, M., Khaw, K. -T., Wareham, N. & 31 others, Allen, N. E., Tsilidis, K. K., Bueno-de-Mesquita, H. B., Jeurnink, S. M., Numans, M. E., Peeters, P. H. M., Lagiou, P., Valanou, E., Trichopoulou, A., Kaaks, R., Lukanova-McGregor, A., Bergman, M. M., Boeing, H., Jonas Manjer, Lindkvist, B., Stenling, R., Hallmans, G., Mortensen, L. M., Overvad, K., Olsen, A., Tjonneland, A., Bakken, K., Dumeaux, V., Lund, E., Jenab, M., Romieu, I., Michaud, D., Mouw, T., Carneiro, F., Fenge, C. & Riboli, E., 2012, In : Annals of Oncology. 23, 5, p. 1320-1324

    Research output: Contribution to journalArticle

  20. Power and limits of modern cancer diagnostics: cancer of unknown primary

    Kari Hemminki, Liu, H., Heminki, A. & Jan Sundquist, 2012, In : Annals of Oncology. 23, 3, p. 760-764

    Research output: Contribution to journalArticle

  21. Primary metastatic Ewing's family tumors: results of the Italian Sarcoma Group and Scandinavian Sarcoma Group ISG/SSG IV Study including myeloablative chemotherapy and total-lung irradiation

    Luksch, R., Tienghi, A., Hall, K. S., Fagioli, F., Picci, P., Barbieri, E., Gandola, L., Mikael Eriksson, Ruggieri, P., Daolio, P., Lindholm, P., Prete, A., Bisogno, G., Tamburini, A., Grignani, G., Abate, M. E., Podda, M., Smeland, S. & Ferrari, S., 2012, In : Annals of Oncology. 23, 11, p. 2970-2976

    Research output: Contribution to journalArticle

  22. Survival in cancer of unknown primary site: population-based analysis by site and histology

    Kari Hemminki, Bevier, M., Hemminki, A. & Jan Sundquist, 2012, In : Annals of Oncology. 23, 7, p. 1854-1863

    Research output: Contribution to journalArticle

  23. 2011
  24. Metabolic syndrome and rare gynecological cancers in the Metabolic syndrome and Cancer project (Me-Can)

    Nagel, G., Concin, H., Bjorge, T., Rapp, K., Jonas Manjer, Hallmans, G., Diem, G., Haggstrom, C., Engeland, A., Martin Almquist, Jonsson, H., Selmer, R., T. Stocks, Tretli, S., Ulmer, H., Stattin, P. & Lukanova, A., 2011, In : Annals of Oncology. 22, 6, p. 1339-1345

    Research output: Contribution to journalArticle

  25. Nonmetastatic Ewing family tumors: high-dose chemotherapy with stem cell rescue in poor responder patients. Results of the Italian Sarcoma Group/Scandinavian Sarcoma Group III protocol

    Ferrari, S., Hall, K. S., Luksch, R., Tienghi, A., Thomas Wiebe, Fagioli, F., Thor Alvegård, del Prever, A. B., Tamburini, A., Alberghini, M., Gandola, L., Mercuri, M., Capanna, R., Mapelli, S., Prete, A., Carli, M., Picci, P., Barbieri, E., Bacci, G. & Smeland, S., 2011, In : Annals of Oncology. 22, 5, p. 1221-1227

    Research output: Contribution to journalArticle

  26. 2010
  27. AIB1 is a predictive factor for tamoxifen response in premenopausal women.

    Alkner, S., Pär-Ola Bendahl, Grabau, D., Lövgren, K., Stål, O., Lisa Rydén & Mårten Fernö, 2010, In : Annals of Oncology. 21, p. 238-244

    Research output: Contribution to journalArticle

  28. Characterisation Of The Hepatic Safety Profile Of Trabectedin: Pooled Analysis Of 19 Phase II Clinical Trials (CTS) In 1132 Patients With Solid Tumours

    Blay, J., Le Cesne, A., Judson, I., Schoffski, P., Sessa, C., Paz-Ares, L., Thomas Högberg, Zintl, P., Parekh, T. V. & Demetri, G. D., 2010, In : Annals of Oncology. 21, Suppl. 8, p. 177-178

    Research output: Contribution to journalPublished meeting abstract

  29. Efficacy and safety of ipilimumab monotherapy in patients with pretreated advanced melanoma: a multicenter single-arm phase II study

    O'Day, S. J., Maio, M., Chiarion-Sileni, V., Gajewski, T. F., Pehamberger, H., Bondarenko, I. N., Queirolo, P., Lundgren, L., Mikhailov, S., Roman, L., Verschraegen, C., Humphrey, R., Ibrahim, R., de Pril, V., Hoos, A. & Wolchok, J. D., 2010, In : Annals of Oncology. 21, 8, p. 1712-1717

    Research output: Contribution to journalArticle

  30. Long-term follow-up after risk-adapted treatment in clinical stage 1 (CS1) nonseminomatous germ-cell testicular cancer (NSGCT) implementing adjuvant CVB chemotherapy. A SWENOTECA study

    Tandstad, T., Cohn-Cedermark, G., Dahl, O., Stierner, U., Cavallin-Ståhl, E., Bremnes, R. M. & Klepp, O., 2010, In : Annals of Oncology. 21, 9, p. 1858-1863

    Research output: Contribution to journalArticle

  31. Results of a phase I/II study of ocrelizumab, a fully humanized anti-CD20 mAb, in patients with relapsed/refractory follicular lymphoma

    Morschhauser, F., Marlton, P., Vitolo, U., Lindén, O., Seymour, J. F., Crump, M., Coiffier, B., Foa, R., Wassner, E., Burger, H. -U., Brennan, B. & Mendila, M., 2010, In : Annals of Oncology. 21, 9, p. 1870-1876

    Research output: Contribution to journalArticle

  32. Second cancers after testicular cancer diagnosed after 1980 in Sweden

    Kari Hemminki, Liu, H. & Jan Sundquist, 2010, In : Annals of Oncology. 21, 7, p. 1546-1551

    Research output: Contribution to journalArticle

  33. STROMA-DERIVED MARKERS PREDICTING BREAST CANCER PROGNOSIS AND TREATMENT RESPONSE

    Ostman, A., Paulsson, J., Liu, T., Lisa Rydén, Karin Jirström, Landberg, G. & Bergh, J., 2010, In : Annals of Oncology. 21, p. 115P

    Research output: Contribution to journalPublished meeting abstract

  34. Vandetanib In Locally Advanced Or Metastatic Differentiated Thyroid Cancer (Papillary Or Follicular; Dtc): A Randomized, Double-Blind Phase Ii Trial

    Leboulleux, S., Bastholt, L., Krause, T. M., De La Fouchardiere, C., Jan Tennvall, Awada, A., Gomez, J. M., Carrasco, A. T., Licour, M. & Schlumberger, M. J., 2010, In : Annals of Oncology. 21, p. 315-315

    Research output: Contribution to journalPublished meeting abstract

  35. 2009
  36. Cancer risk in hospitalized sarcoidosis patients: a follow-up study in Sweden

    J. Ji, Shu, X., Li, X., Kristina Sundquist, Sundquist, J. & Hemminki, K., 2009, In : Annals of Oncology. 20, 6, p. 1121-1126

    Research output: Contribution to journalArticle

  37. DEVELOPMENT OF IMMUNOHISTOCHEMICAL SURROGATES FOR PREDICTION OF BREAST CANCER PATIENT OUTCOME VIA HIGH-THROUGHPUT ANTIBODY GENERATION AND APPLICATION OF TISSUE MICROARRAY TECHNOLOGY: AN INITIAL REPORT

    Dolan, R. T., Brennan, D. J., Rexhepaj, E., Kelly, C. M., Penny, S., Karin Jirström, Ponten, F., Uhlen, M. & Gallagher, W. M., 2009, In : Annals of Oncology. 20, Suppl 2, p. 54-54

    Research output: Contribution to journalPublished meeting abstract

  38. Empirically derived psychosocial states among adolescents diagnosed with cancer during the acute and extended phase of survival

    Mattsson, E., El-Khouri, B., Ljungman, G. & von Essen, L., 2009, In : Annals of Oncology. 20, 10, p. 1722-1727

    Research output: Contribution to journalArticle

  39. IDENTIFICATION OF NOVEL SECRETED TUMOR STROMA-DERIVED STIMULATORS OF PROSTATE CANCER GROWTH

    Ostman, A., Augsten, M., Hagglof, C., Bruzzese, F., Leone, A., Olsson, E., Åke Borg, Egevad, L. & Micke, P., 2009, In : Annals of Oncology. 20, Suppl 3, p. O34-O34

    Research output: Contribution to journalPublished meeting abstract

  40. 2008
  41. a multicentre, phase ii study of cp-4055 in combination with sorafenib in patients with metastatic malignant melanoma

    Dueland, S., Aamdal, S., Nyakas, M., Lundgren, L., Wagenius, G., Ljuslinder, I., Stierner, U., Gaullier, J., Nilsson, B. I. & Rasch, W., 2008, In : Annals of Oncology. 19, p. 245-246

    Research output: Contribution to journalPublished meeting abstract

  42. A randomized phase III multicenter trial comparing irinotecan in combination with the Nordic bolus 5-FU and folinic acid schedule or the bolus/infused de Gramont schedule (Lv5FU2) in patients with metastatic colorectal cancer

    Glimelius, B., Sorbye, H., Balteskard, L., Bystrom, P., Pfeiffer, P., Tveit, K., Heikkila, R., Keldsen, N., Albertsson, M., Starkhammar, H., Garmo, H. & Berglund, A., 2008, In : Annals of Oncology. 19, 5, p. 909-914

    Research output: Contribution to journalArticle

  43. BCL-2 but not FOXP1, is an adverse risk factor in immunochemotherapy treated non-germinal center diffuse large B-cell lymphomas

    Nyman, H., Mats Jerkeman, Karjalainen-Lindsberg, M., Banham, A., Enblad, G. & Leppa, S., 2008, In : Annals of Oncology. 19, Suppl. 4, p. iv 142-iv 142

    Research output: Contribution to journalPublished meeting abstract

  44. Burkitt's lymphoma: Comparison of 2 nationwide population-based lymphoma registries

    Brown, P. D., Samuelsson, V., d'Amore, F., Lindh, J., Hagberg, H., Nilsson, G., Bernell, P., Pedersen, L. M. & Mats Jerkeman, 2008, In : Annals of Oncology. 19, Suppl. 4, p. iv 131-iv 131

    Research output: Contribution to journalPublished meeting abstract

  45. Cytokine gene polymorphisms and the risk of adenocarcinoma of the stomach in the European prospective investigation into cancer and nutrition (EPIC-EURGAST)

    Crusius, J. B. A., Canzian, F., Capella, G., Pena, A. S., Pera, G., Sala, N., Agudo, A., Rico, F., Del Giudice, G., Palli, D., Plebani, M., Boeing, H., Bueno-de-Mesquita, H. B., Carneiro, F., Pala, V., Save, V. E., Vineis, P., Tumino, R., Panico, S., Berglund, G. & 27 others, Manjer, J., Stenling, R., Hallmans, G., Martinez, C., Dorronsoro, M., Barricarte, A., Navarro, C., Quiros, J. R., Allen, N., Key, T. J., Binghan, S., Caldas, C., Linseisen, J., Kaaks, R., Overvad, K., Tjonneland, A., Buechner, F. C., Peeters, P. H. M., Numans, M. E., Clavel-Chapelon, F., Trichopoulou, A., Lund, E., Jenab, M., Rinaldi, S., Ferrari, P., Riboli, E. & Gonzalez, C. A., 2008, In : Annals of Oncology. 19, 11, p. 1894-1902

    Research output: Contribution to journalArticle

  46. Familial characteristics of Waldenström's macroglobulinemia (WM) and lymphoplasmacytic lymphoma (LPL): A population-based study in Sweden

    Kristinsson, S. Y., Bjorkholm, M., Goldin, L. R., McMaster, M. L., Ingemar Turesson & Landgren, O., 2008, In : Annals of Oncology. 19, Suppl. 4, p. iv 166-iv 166

    Research output: Contribution to journalPublished meeting abstract

  47. Guidance on the use of bisphosphonates in solid tumours: recommendations of an international expert panel

    Aapro, M., Abrahamsson, P-A., Body, J. J., Coleman, R. E., Colomer, R., Costa, L., Crinò, L., Dirix, L., Gnant, M., Gralow, J., Hadji, P., Hortobagyi, G. N., Jonat, W., Lipton, A., Monnier, A., Paterson, A. H. G., Rizzoli, R., Saad, F. & Thürlimann, B., 2008, In : Annals of Oncology. 19, 3, p. 420-432

    Research output: Contribution to journalArticle

  48. Mature T-cell lymphoma patients show high relapse rates after high dose therapy followed by autologous transplantation

    Nickelsen, M., Canals, C., Schmitz, N., Glass, B., Leyvraz, S., Engelhard, M., Koza, V., Relander, T., Holowiecki, J., Linkesch, W., Losonczy, H., Meloni, G., Briones, J. & Sureda, A., 2008, In : Annals of Oncology. 19, Suppl. 4, p. iv 113-iv 114

    Research output: Contribution to journalPublished meeting abstract

  49. Nordic Observational Study Evaluating Safety And Analgesic Use In Patients With Advanced Cancer Under Zoledronic Acid Treatment Interim Analysis

    Lindman, H., Ostri, P., Andersen, M., Hagen, E. K., Wiklund, K. & Abrahamsson, P-A., 2008, In : Annals of Oncology. 19, p. 255-255

    Research output: Contribution to journalPublished meeting abstract

  50. Self-selection in sigmoidoscopy screening: A nine-year follow-up study

    Blom, J., Yin, L., Liden, A., Dolk, A., Bengt Jeppsson, Pahlman, L., Holmberg, L. & Nyren, O., 2008, In : Annals of Oncology. 19, Suppl. 6, p. 101-102

    Research output: Contribution to journalPublished meeting abstract